Debate about the quality of research use antibodies and the need for validation has intensified over the past few years. Numerous research manuscripts describing novel biomarkers have reportedly been withdrawn from publication due to mistaken conclusions based on assumed antibody specificity and inadequate controls. Read about Cell Signaling Technology's approach to antibody reproducibility.
Read Article